![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © Springer-Verlag 2007 Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc 1Raymond Purves Laboratory, Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Royal North Shore Hospital, Level 5, University Clinic B26, St. Leonards, NSW 2065 Australia 2Murray Maxwell Biomechanics Laboratory, Department of Orthopaedics and Traumatic Surgery, Royal North Shore Hospital, Block 4, St. Leonards, NSW 2065 Australia James Melrose, Phone: +61-2-99266535, Fax: +61-2-99266539, Email: jmelrose/at/med.usyd.edu.au. Corresponding author.Received May 23, 2007; Revised September 3, 2007; Accepted October 15, 2007. This article has been cited by other articles in PMC.Abstract The aim of this study was to undertake a detailed analysis of the structure of the inter and intra-lamellar regions of the annulus fibrosus. A total of 30 newborn to 6 year-old lumbar ovine intervertebral discs (IVDs) were fixed and decalcified en-bloc to avoid differential swelling artifacts during processing and vertical mid-sagittal, and horizontal 4 μm sections were cut. These were stained with toluidine blue to visualise anionic proteoglycan (PG) species, H & E for cellular morphology and picro-sirius red (viewed under polarized light) to examine collagenous organization. Immunolocalisations were also undertaken using anti-PG core-protein and glycosaminoglycan (GAG) side chain antibodies to native chondroitin sulphate (CS), Δ C-4-S and C-6-S unsaturated stubs generated by chondroitinase ABC digestion of CS, keratan sulphate (KS), and with antibodies to type I, II, VI, IX and X collagens. Trans-lamellar cross bridges (TLCBs), discontinuities in annular lamellae’s which provide transverse interconnections, stained prominently with toluidine blue in the adult IVDs but less so in the newborn IVDs. In adult discs TLCBs were evident in both the posterior and anterior AF where they extended from the outermost annular lamellae almost to the transitional zone extending across as many as eight lamellar layers displaying a characteristic circuitous, meandering, serpentine type course. There were significantly fewer TLCBs in 2 week-old compared with skeletally mature sheep and there was a further increase from 2 to 6 years. Immunolocalisation of perlecan delineated blood vessels in the TLBs of the newborn but not adult IVDs extending into the mid AF. In contrast adult but not 2 week-old TLCBs were immunpositive for C-4-S, C-6-S, KS, aggrecan, versican and type VI collagen. The change in number and matrix components of the trans-lamellar cross bridges with skeletal maturity and ageing suggest that they represent an adaptation to the complex biomechanical forces occurring in the annulus fibrosus. Keywords: Annular cross bridges, Type VI collagen, Aggrecan, Versican Introduction The intervertebral disc (IVD) is the largest predominantly avascular, alymphatic and aneural structure in the human body. It is composed of several connective tissues of dissimilar composition and structure and it is the dynamic interplay between these in the biocomposite IVD which equips it with its unique biomechanical properties and ability to act as a viscoelastic and hydrodynamic weight bearing cushion absorbing and dissipating axial spinal compressive loads [5, 7, 16, 22, 40, 49, 50]. The outermost region of the IVD, the annulus fibrosus (AF) is composed of collagenous lamellae which convey tensile properties and along with the superior and inferior hyaline-like cartilaginous endplates, prevent the inner proteoglycan rich region of the IVD, the nucleus pulposus (NP) being extruded anteriorly or posteriorly during axial and torsional spinal loading. The type I and II collagen fibre networks are arranged at a 60° angle relative to one another in adjacent lamellae [16–19, 22, 40, 49, 50]. Elastic fibres traverse between lamellae where they have a role to play in the recoil properties of these tissues aiding lamellae collagen crimp patterns to return to their pre-loaded dimensions and orientations [4, 6, 24–26, 43, 54–57]. These fibre networks couple adjacent lamellae together such that they work co-operatively during dynamic loading and prevent separation of lamellae during torsional compressive loading. A further adaptation in the AF is the recently described translamellar cross-bridge [41, 42]. This is a discontinuity in the lamellae which traverses and interconnects several annular lamellae. Little is known about the structure and composition of these annular structures. Differential interference contrast microscopy demonstrates that these cross bridges have a high fibre component and both elastin and fibrillin-1 have recently been immunolocalized to these structures [56]. In the present study we have investigated the morphology and the collagen and proteoglycan composition of the translamellar cross-bridges in normal ovine discs of different ages to provide further insights as to their functional roles. Materials and methods All histology consumables were purchased from DAKO-Australia, Botany, Sydney, Australia. Positively charged SuperFrost Plus glass microscope slides were purchased from Menzel-Glaser, GmbH, Germany. Details of the antibodies used and epitope retrieval steps required for detection are provided in table 1 and suppliers are provided below. Monoclonal antibody (Mab) 5-D-5 to versican G3 domain [1, 30, 48] was a gift from Dr Firoz Rahemtulla, University of Alabama, Birmingham, AL, USA. Mab A7L6, rat anti perlecan domain IV [14, 15] and MAb CS-56 to native CS [23] were purchased from Abcam, Cambridge, UK. Mab 12C5 to versican G1 domain originally developed by Dr R Asher [2, 3] was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA, USA. Affinity purified rabbit polyclonal antibodies to aggrecan G1 and G3 domains [39, 46, 51] were gifts from Dr Peter Roughley and Dr John Mort, Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada. Rabbit polyclonal anti bovine type VI collagen was a gift from Dr Betty Reinboth, Department of Pathology, University of Adelaide, Adelaide, Australia. Mabs 3-B-3, 2-B-6 and 5-D-4 [9–13] were gifts from Prof. Bruce Caterson, School of Molecular and Medical Biosciences, University of Cardiff, Cardiff, UK.
Histology Three lumbar IVDs (L2L3, L3L4 and L4L5) from two 2 day-old lambs and 27 lumbar IVDs from groups of sheep aged 2, 4 and 6 years (nine IVDs from each age, three L2L3, three, L3L4 and three L5L6 IVDs) were examined. The IVDs with superior and inferior vertebral bodies attached, were fixed en-bloc in 10% neutral buffered formalin for 1 week then decalcified in several changes of 10% formic acid in 5% formalin for 2 weeks with constant agitation. Vertical mid-sagittal tissue slabs (~5 mm) of the vertebral body-IVD specimens were cut and dehydrated in graded alcohols then double embedded in paraffin-celloidin. Sections (4 μ) were cut using a rotary microtome, and mounted on SuperFrost Plus glass slides. These were dried at 85°C for 30 min followed by 55°C in an oven overnight. Horizontal slices (2 mm) of selected IVDs devoid of vertebral body and hence requiring no decalcification were fixed directly in 10% neutral buffered formalin for 24 h, dehydrated in graded alcohols, embedded in paraffin wax and sections prepared as outlined above. Following de-paraffinisation in xylene and re-hydration through graded ethanol washes (100–70% v/v) to water, the tissue sections were stained with toluidine blue/fast green [20] or picro-sirius red [45], the latter stain was examined by polarised light microscopy. The picrosirius red staining method of Sweat et al. [45] was used after initial removal of tissue proteoglycans as advocated by Junqueira et al. [27] by pre-digestion with bovine testicular hyaluronidase (1,000 U/ml) in 0.1 M phosphate buffer pH 5.0 for 2 h at 37°C. The tissue sections were initially stained in Wiegert’s Iron haematoxylin for 30 min, then in 0.1% Sirius red F3BA in saturated aqueous picric acid for 2 h at room temp. The sections were not rinsed in water since sirius red is soluble in water but were washed rapidly in several changes of iso-propanol, cleared in xylene and mounted in Eukitt. Tissue proteoglycans were stained in 0.04% w/v toluidine blue O in 0.1 M sodium acetate buffer pH 4.0 for 10 min and the sections counterstained with 0.1% w/v aqueous fast green FCF for 2 min. Immunohistology Four micron tissue sections were cut and adhered to positively charged microscope slides as indicated earlier. Incubations with primary antibodies (Table 1) were performed using a Sequenza vertical cover-plate immunostaining system [32–37]. Endogenous peroxidase activity was blocked by incubating the tissue sections with 3% H2O2 for 5 min, washed in water then non-specific binding sites were blocked with a serum free protein block (Dako x0909) or 10% swine serum for 10 min. The perlecan sections were pre-digested with chondroitinase ABC (0.25 U/ml) for 1 h at 37°C in 0.1 M Tris–HCl, 0.03 M sodium acetate buffer pH 8.0, the aggrecan and versican sections were pre-digested for 2 h at 37°C with 0.05 U/ml chondroitinase ABC prior to undertaking the localisations. The tissue sections were incubated overnight at 4°C with anti-perlecan domain-IV antibody A7L6 (5 μg/ml), anti aggrecan G1 or G3 (1:1,000), Mabs 5D5 or 12C5 to versican (1.25 μg/ml) or anti CS (MAb CS-56) 1/1,000 diln diluted in 2% BSA in TBS. Selected tissue sections were pre-digested with chondroitinase ABC (0.25 U/ml) for 2 h prior to undertaking the 3-B-3 and 2-B-6 localisations, these were both used at a dilution of 1/3,000, Mab 5-D-4 to keratan sulphate required no pre-treatment step and was used at a dilution of 1/5,000 [9–13]. After washing in 50 mM Tris–HCl, pH 7.6 containing 150 mM NaCl 0.05% Tween 20 (TBS–Tween) the slides were incubated with appropriate biotinylated goat anti-rabbit, mouse or rat IgG for detection of primary antibody and horse–radish peroxidase or alkaline phosphatase conjugated streptavidin for visualisation using nova red, new fuchsin or diaminobenzidene substrate for colour development. Negative control sections were developed using an isotype matched mouse monoclonal IgG (clone DAK-GO1) against Aspergillus niger glucose oxidase, an enzyme which is neither present nor inducible in mammalian tissues or for the rabbit and rat primary antibodies were undertaken either omitting primary antibody or using concentration matched non-immune rabbit or rat serum instead of authentic primary antibody. The tissue specimens were examined by bright field, Nomarsky DIC or polarised light microscopy using a Leica photomicroscope linked to a DFC 480 digital camera. Results Preliminary examination of toluidine blue stained vertical mid-sagittal sections of IVD revealed discretely stained discontinuities in the AF annular lamellae in all IVDs examined (Fig. 1
The cross-bridges contained anionic proteoglycan which stained strongly with toluidine blue compared to the adjacent annulus (Fig. 2
Immunolocalisation studies using antibodies to specific core protein and GAG side chain epitopes were undertaken to characterise the proteoglycans in the translamellar bridges. Positive staining for chondroitinase-generated chondroitin-4 and -6 sulphate (3-B-3 and 2-B-6, respectively) and keratan sulphate (5-D-4) was evident in cross-bridges of adult (Fig. 6
Discussion The translamellar cross-bridges we have described in the present study are discrete discontinuities in the normal lamellar layers of the AF, they occur from birth to old age but are less readily visualised in newborn IVDs. Proteoglycans are not obviously associated with the translamellar structures in newborn IVDs however small blood vessels penetrate in a serpentine fashion along these structures into the mid AF and can be visualised using antibodies to specific basement membrane components laid down by the endothelial cells (perlecan) to form these vessel networks [35]. Nomarski DIC optics further confirmed the functional status of these vessels by demonstrating they contained red blood cells. These annular blood vessels are transient entities in the developing IVD and they regress with neonatal maturational developmental changes when an increase in proteoglycans occurs concomitant with an increase in the internal hydrostatic pressure in the IVD as it becomes a weight bearing spinal structure [21, 35]. With increasing age the annular cross-bridges become prominent due to the localisation of anionic proteoglycans in these structures which are readily stained by common anionic dyes such as toluidine blue. These toluidine blue stained cross-lamellar bridges were more numerous per lamella and extended a greater depth into the AF with skeletal maturity suggesting that this may represent a functional adaptation to intrinsic biomechanical forces experienced by the disc. We have shown for the first time that aggrecan and versican are localised in the translamellar cross-bridges. However, the cross bridges are distinct from surrounding collagenous lamellae in having a matrix rich in type VI collagen in adult IVDs but no discernable type VI collagen in newborn IVDs, again suggestive of a mechanically driven, age dependant, adaptive change in these connective tissues. The cross-bridges also contain some type I collagen but no detectable type II, IX or X collagen. The progressive increase in GAG containing cross-bridges with age also suggests that this is an adaptation to mechanical loading in the IVD. However, the lack of expression of type II collagen (but abundant type VI collagen) makes the cross bridges distinct from other tensional tissue adaptations to loading such as evident in the compressed regions of tendons or inner meniscus where aggrecan and type II and IX collagen are increased [33]. A role for aggrecan and versican in the lubrication of collagen bundles to facilitate the sliding of tendon fascicles over one another has been suggested to prevent fibril damage during twisting movements under extreme load [52, 53]. Connective tissues containing collagen bundles which occur at variable angles to one another are subject to focal transverse compressive load even in tissues which are generally considered to be tensional. The small islands of rounded cells of a chondrocytic phenotype in the mid-meniscus in a matrix rich in anionic proteoglycan (aggrecan) and type II collagen, may be one such example of focal compressive load leading to phenotypic adaptation of intrinsic cell populations [33]. Type VI collagen accumulates in regions of deep flexor digital tendon around nests of cells experiencing focal compressive load and has been suggested as a marker of fibrocartilage differentiation [8]. The supraspinatus tendon of the human rotator cuff contains a number of structurally independent fascicles which can be variably and independently loaded depending on joint angulation. Inter-fascicular proteoglycan rich regions play a role in the lubrication of these units minimising shear stresses. The annular lamellae of the IVD are also variably loaded with a lamella under tension occurring adjacent to one that is relaxed [41, 42, 47]. The interlamellar regions of the IVD are also proteoglycan-rich. Versican is localised in such annular junctional regions where it may play a similar role to the fascicle associated proteoglycans in tendon [34]. The proposal of versican and aggrecan acting as lubricating agents is a new role for these proteoglycans in the IVD but consistent with roles proposed for CS–PGs in tendon. Furthermore, type VI collagen is capable of interacting with hyaluronan, a well known lubricating component of synovial fluids [28, 29, 31, 44, 52, 53] and this association may also facilitate the lubrication of collagen bundles. Trans lamellar cross-bridges have also been observed in the human AF [55, 56]. We hypothesis that these cross-bridges represent an adaptation to the complex tensional and compressional loading of the annular lamellae. Therefore any change in disc mechanics that may occur with NP degeneration may also influence the cross-bridges. Future studies will attempt to examine the relationship between the cross bridges and NP degeneration in animal models. Contributor Information James Melrose, Phone: +61-2-99266535, Fax: +61-2-99266539, Email: jmelrose/at/med.usyd.edu.au. Susan M. Smith, Email: sues/at/staff.usyd.edu.au. Richard C. Appleyard, Email: appleyardr/at/med.usyd.edu.au. Christopher B. Little, Email: cblittle/at/med.usyd.edu.au. References 1. Abiko Y, Nishimura M, Rahemtulla F, Mizoguchi I, Kaku T (2001) Immunohistochemical localisation of large chondroitin sulphate proteoglycan in porcine gingival epithelia. Eur J Morphol 39:99–104 [PubMed] 2. Asher RA, Perides G, Vanderhaeghen J-J, Bignani A (1991) Extracellular matrix of central bervous system white matter: demonstration of an hyaluronate-protein complex. J Neurosci Res 28:410–421 [PubMed] 3. Asher RA, Schiebe RJ, Keiser HD, Bignami A (1995) On the existence of a cartilage like proteoglycan and link protein in the central nervous system. Glia 13:294–308 [PubMed] 4. Boszczyk BM, Boszczyk AA, Putz R, Buttner A, Benjamin M, Milz S (2001) An immunohistochemical study of the dorsal capsule of the lumbar and thoracic facet joints. Spine 26: E338–E343 [PubMed] 5. Buckwalter JA (1995) Aging and degeneration of the human intervertebral disc. Spine 20:1307–1314 [PubMed] 6. Buckwalter JA, Cooper RR, Maynard JA (1976) Elastic fibers in human intervertebral discs. J Bone Joint Surg Am 58:73–76 [PubMed] 7. Buckwalter JA, Woo SL, Goldberg VM, Hadley EC, Booth F, Oegema TR, Eyre DR (1993) Soft-tissue aging and musculoskeletal function. J Bone Joint Surg Am 75:1533–1548 [PubMed] 8. Carvalho HF, Felisbino SL, Keene DR, Vogel KG (2006) Identification, content, and distribution of type VI collagen in bovine tendons. Cell Tissue Res 325:315–324 [PubMed] 9. Caterson B, Baker JR, Christner JE, Couchman JR (1982) Immunological methods for the detection and determination of connective tissue proteoglycans. J Invest Dermatol 79(Suppl 1):45s–50s [PubMed] 10. Caterson B, Calabro T, Hampton A (1987) Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Wright T, Mecham R (eds) Biology of Proteoglycans. Academic, New York, pp 1–26 . 11. Caterson B, Christner JE, Baker JR, Couchman JR (1985) Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 44:386–393 [PubMed] 12. Caterson B, Christner JE, Baker JR, Couchman JR (1985) Production and characterisation of monoclonal antibodies against connective tissue proteoglycans. Fed Proc Fed Am Soc Exp Biol 44:386–393 [PubMed] 13. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney SL, Ratcliffe A, Muir H (1990) Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 97:411–417 [PubMed] 14. Couchman JR, Ljubimov AV (1989) Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. Matrix 9:311–321 [PubMed] 15. Couchman JR, Ljubimov AV, Sthanam M, Horchar T, Hassell JR (1995) Antibody mapping and tissue localization of globular and cysteine rich regions of perlecan domain III. J Histochem Cytochem 43:955–963 [PubMed] 16. Eyre DR (1979) Biochemistry of the intervertebral disc. Int Rev Connect Tissue Res 8:227–291 [PubMed] 17. Eyre DR, Muir H (1974) Collagen polymorphism: two molecular species in pig intervertebral disc. FEBS Lett 42:192–196 [PubMed] 18. Eyre DR, Muir H (1976) Types I and II collagens in intervertebral disc. Interchanging radial distributions in annulus fibrosus. Biochem J 157:267–270 [PubMed] 19. Eyre DR, Muir H (1977) Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. Biochim Biophys Acta 492:29–42 [PubMed] 20. Getzy LL, Malemud CJ, Goldberg VM, Moskowitz RW (1982) Factors influencing metachromatic staining in paraffin embedded sections of rabbit and human articular cartilage: a comparison of the Safranin O and toluidine blue techniques. J Histotechnol 5:111–116 . 21. Hayes AJ, Benjamin M, Ralphs JR (2001) Extracellular matrix in development of the intervertebral disc. Matrix Biol 20:107–121 [PubMed] 22. Humzah MD, Soames RW (1988) Human intervertebral disc: structure and function. Anat Rec 220:337–356 [PubMed] 23. Ito Y, Hikino M, Yajima Y, Mikami T, Sirko S, von Holst A, Faissner A, Fukui S, Sugahara K (2005) Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology 15:593–603 [PubMed] 24. Johnson EF, Berryman H, Mitchell R, Wood WB (1985) Elastic fibres in the anulus fibrosus of the adult human lumbar intervertebral disc. A preliminary report. J Anat 143:57–63 [PubMed] 25. Johnson EF, Caldwell RW, Berryman HE, Miller A, Chetty K (1984) Elastic fibers in the anulus fibrosus of the dog intervertebral disc. Acta Anat (Basel) 118:238–242 [PubMed] 26. Johnson EF, Chetty K, Moore IM, Stewart A, Jones W (1982) The distribution and arrangement of elastic fibres in the intervertebral disc of the adult human. J Anat 135:301–309 [PubMed] 27. Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455 [PubMed] 28. Kielty CM, Whittaker SP, Grant ME, Shuttleworth CA (1991) Type VI collagen forms a structural association with hyaluronan in vivo. Biochem Soc Trans 19:384S [PubMed] 29. Kielty CM, Whittaker SP, Grant ME, Shuttleworth CA (1992) Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol 118:979–990 [PubMed] 30. Mazzucato M, Cozzi MR, Pradella P, Perissinotto D, Malmstrom A, Morgelin M, Spessotto P, Colombatti A, De Marco L, Perris R (2002) Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. Faseb J 16:1903–1916 [PubMed] 31. McDevitt CA, Marcelino J, Tucker L (1991) Interaction of intact type VI collagen with hyaluronan. FEBS Lett 294:167–170 [PubMed] 32. Melrose J, Smith S, Cake M, Read R, Whitelock J (2005) Perlecan displays variable spatial and temporal immunolocalisation patterns in the articular and growth plate cartilages of the ovine stifle joint. Histochem Cell Biol 123:561–571 [PubMed] 33. Melrose J, Smith S, Cake M, Read R, Whitelock J (2005) Spatial and temporal immunolocalisation of perlecan in the ovine meniscus. Histochem Cell Biol 124:225–235 [PubMed] 34. Melrose J, Smith S, Ghosh P (2000) Differential expression of proteoglycan epitopes by ovine intervertebral disc cells. J Anat 197(Pt 2):189–198 [PubMed] 35. Melrose J, Smith S, Ghosh P, Whitelock J (2003) Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine. J Histochem Cytochem 51:1331–1341 [PubMed] 36. Melrose J, Smith S, Knox S, Whitelock J (2002) Perlecan, the multidomain HS-proteoglycan of basement membranes, is a prominent pericellular component of ovine hypertrophic vertebral growth plate and cartilaginous endplate chondrocytes. Histochem Cell Biol 118:269–280 [PubMed] 37. Melrose J, Smith S, Whitelock J (2004) Perlecan immunolocalises to perichondral vessels and canals in human foetal cartilagenous promordia in early vascular and matrix remodelling events associated with diarthrodial-joint development. J Histochem Cytochem 52:1405–1413 [PubMed] 38. Mort JS, Buttle DJ (1999) The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mol Pathol 52:11–18 [PubMed] 39. Mort JS, Roughley PJ (2004) Production of antibodies against degradative neoepitopes in aggrecan. Methods Mol Med 100:237–250 [PubMed] 40. Oegema TR Jr (1993) Biochemistry of the intervertebral disc. Clin Sports Med 12:419–439 [PubMed] 41. Pezowicz CA, Robertson PA, Broom ND (2005) Intralamellar relationships within the collagenous architecture of the annulus fibrosus imaged in its fully hydrated state. J Anat 207:299–312 [PubMed] 42. Pezowicz CA, Robertson PA, Broom ND (2006) The structural basis of interlamellar cohesion in the intervertebral disc wall. J Anat 208:317–330 [PubMed] 43. Smith LJ, Fazzalari NL (2006) Regional variations in the density and arrangement of elastic fibres in the anulus fibrosus of the human lumbar disc. J Anat 209:359–367 [PubMed] 44. Specks U, Mayer U, Nischt R, Spissinger T, Mann K, Timpl R, Engel J, Chu M (1992) Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. Embo J 11:4281–4290 [PubMed] 45. Sweat F, Puchtler H, Rosenthal SI (1964) Sirius red F3ba as a stain for connective tissue. Arch Pathol 78:69–72 [PubMed] 46. Sztrolovic R, White RJ, Roughley PJ, Mort JS (2002) The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism. Biochem J 362:465–472 [PubMed] 47. Taylor TK, Melrose J, Burkhardt D, Ghosh P, Claes LE, Kettler A, Wilke HJ (2000) Spinal biomechanics and aging are major determinants of the proteoglycan metabolism of intervertebral disc cells. Spine 25:3014–3020 [PubMed] 48. Toriya N, Takuma T, Arakawa T, Abiko Y, Sasano Y, Takahashi I, Sakakura Y, Rahemtulla F, Mizoguchi I (2006) Expression and localisation of versican during postnatal development of rat temporomandibular joint disc. J Histochem Cell Biol 125:205–214 . 49. Urban JP, Roberts S (2003) Degeneration of the intervertebral disc. Arthritis Res Ther 5:120–130 [PubMed] 50. Urban JPG, Roberts S, Ralphs JR (2000) The nucleus of the intervertebral disc from development to degeneration. Am Zool 40:53–61 . 51. Valiyaveettil M, Mort JS, McDevitt CA (2005) The concentration, gene expression, and spatial distribution of aggrecan in canine articular cartilage, meniscus, and anterior and posterior cruciate ligaments: a new molecular distinction between hyaline cartilage and fibrocartilage in the knee joint. Connect Tissue Res 46:83–91 [PubMed] 52. Vogel KG (2004) What happens when tendons bend and twist? Proteoglycans. J Musculoskel Neuron Interact 4:202–203 . 53. Vogel KG, Peters JA (2005) Histochemistry defines a proteoglycan-rich layer in bovine flexor tendon subjected to bending. J Musculoskelet Neuronal Interact 5:64–69 [PubMed] 54. Yu J (2002) Elastic tissues of the intervertebral disc. Biochem Soc Trans 30:848–852 [PubMed] 55. Yu J, Fairbank JC, Roberts S, Urban JP (2005) The elastic fiber network of the anulus fibrosus of the normal and scoliotic human intervertebral disc. Spine 30:1815–1820 [PubMed] 56. Yu J, Tirlapur U, Fairbank J, Handford P, Roberts S, Winlove CP, Cui Z, Urban J (2007) Microfibrils, elastin fibres and collagen fibres in the human intervertebral disc and bovine tail disc. J Anat 210:460–471 [PubMed] 57. Yu J, Winlove PC, Roberts S, Urban JP (2002) Elastic fibre organization in the intervertebral discs of the bovine tail. J Anat 201:465–475 [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Spine (Phila Pa 1976). 1995 Jun 1; 20(11):1307-14.
[Spine (Phila Pa 1976). 1995]J Bone Joint Surg Am. 1993 Oct; 75(10):1533-48.
[J Bone Joint Surg Am. 1993]Int Rev Connect Tissue Res. 1979; 8():227-91.
[Int Rev Connect Tissue Res. 1979]Anat Rec. 1988 Apr; 220(4):337-56.
[Anat Rec. 1988]Clin Sports Med. 1993 Jul; 12(3):419-39.
[Clin Sports Med. 1993]Int Rev Connect Tissue Res. 1979; 8():227-91.
[Int Rev Connect Tissue Res. 1979]Biochim Biophys Acta. 1977 May 27; 492(1):29-42.
[Biochim Biophys Acta. 1977]Anat Rec. 1988 Apr; 220(4):337-56.
[Anat Rec. 1988]Clin Sports Med. 1993 Jul; 12(3):419-39.
[Clin Sports Med. 1993]Arthritis Res Ther. 2003; 5(3):120-30.
[Arthritis Res Ther. 2003]Eur J Morphol. 2001 Apr; 39(2):99-104.
[Eur J Morphol. 2001]FASEB J. 2002 Dec; 16(14):1903-16.
[FASEB J. 2002]Matrix. 1989 Aug; 9(4):311-21.
[Matrix. 1989]J Histochem Cytochem. 1995 Sep; 43(9):955-63.
[J Histochem Cytochem. 1995]Glycobiology. 2005 Jun; 15(6):593-603.
[Glycobiology. 2005]Arch Pathol. 1964 Jul; 78():69-72.
[Arch Pathol. 1964]Histochem J. 1979 Jul; 11(4):447-55.
[Histochem J. 1979]Histochem Cell Biol. 2005 Jun; 123(6):561-71.
[Histochem Cell Biol. 2005]J Histochem Cytochem. 2004 Nov; 52(11):1405-13.
[J Histochem Cytochem. 2004]J Invest Dermatol. 1982 Jul; 79 Suppl 1():45s-50s.
[J Invest Dermatol. 1982]J Cell Sci. 1990 Nov; 97 ( Pt 3)():411-7.
[J Cell Sci. 1990]J Histochem Cytochem. 2003 Oct; 51(10):1331-41.
[J Histochem Cytochem. 2003]Matrix Biol. 2001 Apr; 20(2):107-21.
[Matrix Biol. 2001]Histochem Cell Biol. 2005 Sep; 124(3-4):225-35.
[Histochem Cell Biol. 2005]J Musculoskelet Neuronal Interact. 2005 Mar; 5(1):64-9.
[J Musculoskelet Neuronal Interact. 2005]Histochem Cell Biol. 2005 Sep; 124(3-4):225-35.
[Histochem Cell Biol. 2005]Cell Tissue Res. 2006 Aug; 325(2):315-24.
[Cell Tissue Res. 2006]J Anat. 2005 Oct; 207(4):299-312.
[J Anat. 2005]J Anat. 2006 Mar; 208(3):317-30.
[J Anat. 2006]Spine (Phila Pa 1976). 2005 Aug 15; 30(16):1815-20.
[Spine (Phila Pa 1976). 2005]J Anat. 2007 Apr; 210(4):460-71.
[J Anat. 2007]